I am a retired medical device executive that now spends my days trying to find companies with a compelling business thesis to invest in. Back in the spring of 2016 I became very intrigued in the emerging field of regenerative medicine. At the time there were about 600 organizations developing regenerative products which has since expanded to over 959+ companies worldwide today. Four years ago I spent considerable time reviewing several hundred companies and created a list of the top 10 I believed could become highly successful businesses if their products were proven clinically. Ultimately,